Characterization of Cytokines in a Patient with Acute Rhinosinusitis

Abstract

Despite the improvement in the methods of diagnosis, treatment and prevention of acute rhinosinusitis (ARS), the incidence in childhood ranges from 60 to 75%, and the mortality rate is 0.01-0.2% of cases. This is due to general intoxication, a decrease in the specific and non-specific defenses of the body, which lead to the development of secondary complications from the internal organs. One of the serious complications of ARS in patient infants is brain damage. This sharply increases the risk of developing meningoencephalopathic complications leading to an unfavorable outcome of the underlying disease.